Market Analysis - (2021) Volume 7, Issue 6
Market Analysis
Conference Series LLC Ltdsummon all the participants from all ov er the world to attend International Conference on Applied Microbiology and Infectious Diseases during September 25-26, 2020 at Online ev ent w hich includes key note presentations, Oral talks, Poster presentations and Ex hibitions.
Applied Microbiology 2020 will be held in Online Ev ent from September 25- 26, 2020.
Applied Microbiology 2020 aims to prov ide a platform where academics and practitioners from cross-disciplinary fields from education, env ironmental protection industry , and business can come together and collaborate. The ev ent will encourage the ex ploration of the potential sy nergies that may arise from pooling the different perspectiv es. We inv ite y ou to submit papers on Applied Microbiology . Poster and oral presentations, and thesis presentations will be included in the Conference Program. Applied Microbiology cov ers all aspects of Microbiology and Pathology , and broadly encompasses Microbiology processes, and Atmospheric Changes, Infectious Diseases. It also considers the interactions between humans and these sy stems.
Global Applied Microbiology
The global v irology market is estimated at $1693 million in 2017 and is estimated to grow at a CAGR of 5.4% during the forecast period 2018-2023. North America is the largest v irology market led by the U.S., ow ing to technological adv ancements such as rapid, portable diagnostics. North America is ex pected to retain the top market position ov er the forecast period as well.
Europe is projected to maintain the position as the second largest market globally . During the forecast period, Europe is anticipated to record the highest CAGR, attributed by enhanced healthcare infrastructure, facilitated access to diagnostics, and growing affordability of diagnostic tests for v iral diseases.
Vancouv er is currently a growing microbiology market, which is estimated to grow at a remarkable CAGR through to 2025. How ev er, APEJ and Africa are ex pected to witness the most promising growth opportunities during the forecast period. While China will be a leading APEJ market, India will contribute a considerable rev enue share to the APEJ v irology market.
Key Players in the Global Microbilogy Market
The notable play ers identified in the global v irology market include Glax oSmithKline plc, Abbott Laboratories, Boehringer Ingelheim Corporation, Merck and Co. Inc., Nov artis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche.
Merck and Co. Inc. has sev eral drug candidates in phase 2, including cancer, diabetes, cardiac arrest, and hepatitis C, and some candidates in phase 3, including breast cancer, atherosclerosis, Alzheimer's, Ebola, and HIV. The company also has many other candidates, which are currently under rev iew .
Abiv ax , a high-profile biotech company in Paris, France, has already successfully produced candidates against dengue and chikunguny a v iruses. The company has a few more candidates against HIV and Ebola, currently under dev elopment.
On the basis of diagnosis tests, hepatitis B, Hepatitis C, HIV, Human papillomav irus (HPV), and other tests (like influenza, Ebola, and dengue) are estimated to hold the largest market share globally during the forecast period. Viral Infection controlling Methods include Immunoprophy lax is, Activ e Prophy lax is (Vaccines), Passiv e Prophy lax is, Antiv iral Chemotherapy (Veridical Agents, Antiv iral Agents, Immunomodulators), Interferon’s (Cy tokines). Immunoprophy lax is therapy and antiv iral drugs are the fastest growing market segments in the estimated forecast period.
Virology Market is segmented By Applications into Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract infection, Ey e Infections, Sex ually Transmitted Diseases, Perinatal Infections. STDs, Urinary tract infections, and respiratory tract infections are currently dominating as compared to the other application ty pes in the global v irology market. Virology Market is segmented By End Users into Hospitals, Clinics, Laboratories, Diagnostic Centres, Blood Banks, and Pharmacies.
Global Vaccines Market
The global v accine market is driv en by the rise in prev alence of infectious diseases, as it is considered to be the best way to prev ent such diseases. In addition, emerging v accines (Zika v accines, dengue v accines, cancer v accines, and others), production of technologically adv anced v accines, adv ancements in v accine deliv ery dev ices, and increase in immunization programs supplement the market growth.
According to the market research study in 2016, the global v accines market was worth US$ 28.0 Bn and is projected to reach a v alue of US$ 48.0 Bn by the end of 2025. The market is predicted to register a promising 6.0% CAGR between 2017 and 2025.
Competitive Market Share
Some of the major play ers in global market are AstraZeneca, Abbott, Bristol- My ers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, Glax oSmithKline, Emergent BioSolutions, Nov artis, AstellasPharma, CSL and Nov av ax. Industry play ers focus on new product dev elopment, mergers, and acquisition to strengthen their market position. Companies should face intense competition for dev elopment of nov el products.
Why to attend?
Our Conference will prov ide a perfect platform addressing:
• Laudable talks by the top-notch of the global scientific community
• Sterling w orkshop sessions
• Remarkable Aw ards and Global Recognition to meritorious Researchers
• Global Netw orking w ith 50+ Countries
• Nov el Techniques to Benefit Your Research
The most critical commitment of microbiology to the pharmaceutical business is the improvement of anti-infection agents. All anti-infection agents were initially the results of microbial digestion; how ev er the recent research has enabled the production of more improv ed medications. Vaccines are likew ise an important contribution of microbiology tow ards the drug dev elopment. Vaccine production usually requires culturing of huge amounts of bacteria. Steroids are also produced from microorganisms. Microbiology also contributes tow ards quality control of a pharmaceutical lab.
Probiotics are contained with a range of food and nutrition products such as dietary supplements, medicinal foods, biopharmaceuticals and medical dev ices deliv ering probiotics. Prebiotics foods are taken as dietary ingredients to maintain the Biological Symbiosis with the microbial flora. Dietary supplements created through the sy nergism of Pro and Pre-biotic are the Sy nbiotics. The nutrition supplemented with the beneficial microbial flora and the associated microbiome in human gut, restoring the human digestive system as a w hole is said to be the “ Probiotics” .
Journal of Antimicrobial Agents received 444 citations as per Google Scholar report
